AFM
ENZN

Anson Funds Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Anson Funds Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-25,000
Closed -$17K – 112
2015
Q4 		$17K Buy
+25,000
New +$19.8K 0.01% 96

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Anson Funds Management's ENZN Position: Q1 2016 in Review

Anson Funds Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2016, closing a stake of 25,000 shares — an estimated $17K sold.

Anson Funds Management first reported a position in ENZN in Q4 2015 and held it in 1 quarter. The position peaked at $17K in Q4 2015. 40 funds tracked by Wall St. Rank hold ENZN as of Q1 2016.

  • Anson Funds Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2016 after selling out during the quarter.
  • Anson Funds Management sold 25,000 ENZON PHARMACEUTICALS INC shares in Q1 2016, an estimated $17K.
  • Anson Funds Management first reported a position in ENZON PHARMACEUTICALS INC in Q4 2015 and held it in 1 quarter.
  • Anson Funds Management's ENZON PHARMACEUTICALS INC position peaked at $17K in Q4 2015.
  • 40 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2016.

Based on Anson Funds Management's 13F filing for Q1 2016, filed 13 May 2016.